Africa Corporate Wellness Market, by End User, 2018-2027
| Label | Serum Biomarkers | Hepatic Fibrosis Biomarkers | Apoptosis Biomarkers | Oxidative Stress Biomarkers | Others |
|---|---|---|---|---|---|
| 2016 | 86.9 USD Mn | 59.1 USD Mn | 40 USD Mn | 31.8 USD Mn | 20 USD Mn |
| 2017 | 147.1 USD Mn | 98.4 USD Mn | 67.7 USD Mn | 53.7 USD Mn | 33.8 USD Mn |
| 2018 | 216.4 USD Mn | 142.4 USD Mn | 99.5 USD Mn | 78.8 USD Mn | 49.7 USD Mn |
| 2019 | 280.6 USD Mn | 182.6 USD Mn | 128.9 USD Mn | 102.1 USD Mn | 64.3 USD Mn |
| 2020 | 349.7 USD Mn | 225.5 USD Mn | 160.3 USD Mn | 126.9 USD Mn | 79.7 USD Mn |
| 2021 | 429.9 USD Mn | 276.8 USD Mn | 196.4 USD Mn | 155.3 USD Mn | 97.4 USD Mn |
| 2022 | 520 USD Mn | 335.7 USD Mn | 236.5 USD Mn | 187 USD Mn | 116.6 USD Mn |
| 2023 | 620.4 USD Mn | 403.7 USD Mn | 280.4 USD Mn | 221.5 USD Mn | 137.3 USD Mn |
| 2024 | 731.9 USD Mn | 482.5 USD Mn | 327.7 USD Mn | 259 USD Mn | 159.6 USD Mn |
Data Source: Wantstats Repository
Market Dynamics
Serum Biomarkers segment accounted for the largest market share in the nash biomarker market, and is expected to reach USD 731.90 Million in 2024 from USD 216.40 Million in 2018. However, Hepatic Fibrosis Biomarkers segment is the fastest growing market, which is expected to grow at a CAGR of 21.45% during the forecast period 2019 - 2024.
Research Methodology
Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2023.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



